Thomas K Equels Aim Immuno Tech Inc. (AIM) insider trading activity

AIM Quotes by TradingView

Thomas K Equels is CEO & President of AIM ImmunoTech Inc.. Currently has a direct ownership of 1.68 Million shares of AIM, which is worth approximately $336,139. The most recent transaction as insider was on Feb 24, 2021, when has been sold 11,062 shares (Common Stock) at a price of $2.26 per share, resulting in proceeds of $25,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.68M
12.57% 3M change
162.32% 12M change
Total Value Held $336,139

Thomas K Equels Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2021
BUY
Open market or private purchase
$25,000 $2.26 p/Share
11,062 Added 5.01%
209,630 Common Stock
Dec 17 2020
BUY
Open market or private purchase
$25,000 $1.72 p/Share
14,535 Added 6.82%
198,568 Common Stock
TKE

Thomas K Equels

CEO & President
Ocala, FL

Track Institutional and Insider Activities on AIM

Follow AIM ImmunoTech Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIM shares.

Notify only if

Insider Trading

Get notified when an Aim Immuno Tech Inc. insider buys or sells AIM shares.

Notify only if

News

Receive news related to AIM ImmunoTech Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AIM